Dissolving stent could revolutionize heart disease treatment
NCT ID NCT05206084
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests a new type of heart stent made from iron that slowly dissolves over time, coated with a drug to keep arteries open. It involves 518 adults with coronary artery disease who will receive either the dissolving stent or a standard permanent stent. The goal is to see if the new stent is as safe and effective, with the potential to leave no permanent implant behind.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System (a dissolving metal stent coated with a drug to prevent artery re-narrowing)
- What this could lead to
- If it works, this could offer a safer alternative to permanent metal stents, potentially reducing long-term complications and the need for lifelong medication.
- What could go wrong
- This is an early-stage trial with 518 participants, so results may not apply to everyone. The dissolving scaffold might not perform as well as standard stents, and there is a risk of artery blockage or scaffold failure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fuwai Yunnan Cardiovascular Hospital
Kunming, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Software-Guided heart procedures: a new standard for coronary care?
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program
- Can balloon timing make or break heart artery success?
- Can we predict which heart aneurysms will grow?
- Can a higher dose of adenosine sharpen heart scans?